Healthcare and Pharmaceuticals industry

Global Cetirizine Hydrochloride Market Size Share Forecast 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Cetirizine hydrochloride is a second-generation histamine H1 antagonist that is effective in treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Cetirizine does not cause drowsiness or anticholinergic side effects opposed to conventional antihistamines. Cetirizine is available in various forms such as regular and chewable tablets, capsules, and solutions.
Market Dynamics
Increasing prevalence of allergic conditions in children and adult population is major factor driving growth of the cetirizine hydrochloride market. According to the National Health Interview Survey (NHIS), 2014, around 8.4% of children under the age of 18 suffered from hay fever, 10% from respiratory allergies, 5.4% from food allergies, and 11.6% from skin allergies in the U.S. Furthermore, allergic conjunctivitis imposes economic and social burden on the affected population, thereby increasing the adoption of efficient treatment to curb the increasing healthcare costs. According to the Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2013, an estimated 6 million people are affected by bacterial conjunctivitis, annually in the U.S. The total expenditure in treatment of the disease was reported around US $377 million to US$ 857 million, annually.
Key features of the study:

This report provides in-depth analysis of the cetirizine hydrochloride market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global cetirizine hydrochloride market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global cetirizine hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cetirizine hydrochloride market

Detailed Segmentation:

Global Cetirizine Hydrochloride Market, By Dosage Form:

Tablet
Syrup
Solution

Global Cetirizine Hydrochloride Market, By Age Group:

Adult
Pediatric

Global Cetirizine Hydrochloride Market, By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

Global Cetirizine Hydrochloride Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Cetirizine Hydrochloride Market, By Geography:

North America

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

U.S.
Canada


Latin America

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

Brazil
Mexico
Argentina
Rest of Latin America


Europe

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe


Asia Pacific

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific


Middle East

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

GCC
Israel
Rest of Middle East


Africa

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

South Africa
Central Africa
North Africa



Company Profiles

Johnson and Johnson*

Company Overview
Product Portfolio
Financial Performance
Recent Developments
Market Strategies

Mylan, Inc.
Nicox S.A.
Strides Shasun
Apotex, Inc.
Teva UK Limited
Aurobindo Pharma Limited
Jubiliant Life Sciences
Tris Pharma, Inc.
Cipla Ltd.


“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Dosage Form
o Market Snippet, By Age Group
o Market Snippet, By Application
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Market Trends
o Regulatory Scenario
o Impact Analysis
o Key Highlights
o PEST Analysis
o Epidemiology
4. Global Cetirizine Hydrochloride Market, By Dosage Form, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Tablet
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Syrup
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Solution
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
5. Global Cetirizine Hydrochloride Market, By Age Group, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Adult
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Pediatric
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
6. Global Cetirizine Hydrochloride Market, By Application, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Allergic Rhinitis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Allergic Conjunctivitis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Eczema
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
7. Global Cetirizine Hydrochloride Market, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Hospital Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Online Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
8. Global Cetirizine Hydrochloride Market, By Region, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, By Region, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, For Regions, 2017-2026
o North America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o U.S.
o Canada
o Latin America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o South Africa
o Central Africa
o North Africa
9. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Johnson and Johnson
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Mylan, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Nicox S.A.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Strides Shasun
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Apotex, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Teva UK Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Aurobindo Pharma Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Jubiliant Life Sciences
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Tris Pharma, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Cipla Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 28 market data tables and 28 figures on "Cetirizine Hydrochloride Market - Global forecast to 2026".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.